Log In
BCIQ
Print this Print this
 

RI-002

  Manage Alerts
Collapse Summary General Information
Company ADMA Biologics Inc.
DescriptionHuman plasma-derived, polyclonal, IV immunoglobulin (IVIG) that has standardized high levels of antibodies against respiratory syncytial virus (RSV)
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

01/10/2013

Undisclosed

0

Undisclosed

Get a free BioCentury trial today